Cargando…

Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders

The relevance of the polymorphic form, particle size, and processing of mannitol for the mechanical properties of solid oral dosage forms was examined. Thus, particle and powder properties of spray granulated β D-mannitol, β D-mannitol, and δ D-mannitol were assessed in this study with regards to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mareczek, Lena, Riehl, Carolin, Harms, Meike, Reichl, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611586/
https://www.ncbi.nlm.nih.gov/pubmed/36297563
http://dx.doi.org/10.3390/pharmaceutics14102128
_version_ 1784819563938971648
author Mareczek, Lena
Riehl, Carolin
Harms, Meike
Reichl, Stephan
author_facet Mareczek, Lena
Riehl, Carolin
Harms, Meike
Reichl, Stephan
author_sort Mareczek, Lena
collection PubMed
description The relevance of the polymorphic form, particle size, and processing of mannitol for the mechanical properties of solid oral dosage forms was examined. Thus, particle and powder properties of spray granulated β D-mannitol, β D-mannitol, and δ D-mannitol were assessed in this study with regards to their manufacturability. D-mannitol is a commonly used excipient in pharmaceutical formulations, especially in oral solid dosage forms, and can be crystallized as three polymorphic forms, of which β is the thermodynamically most stable form and δ is a kinetically stabilized polymorph. A systematic analysis of the powders as starting materials and their respective roller compacted granules is presented to elucidate the multidimensional effects of powder and granules characteristics such as polymorphic form, particle size, and preprocessing on the resulting tablets’ mechanical properties. In direct compression and after roller compaction, δ polymorph displayed superior tableting properties over β mannitol, but was outperformed by spray granulated β mannitol. This could be primarily correlated to the higher specific surface area, leading to higher bonding area and more interparticle bonds within the tablet. Hence, it was shown that surface characteristics and preprocessing can prevail over the impact of polymorphism on manufacturability for oral solid dosage forms.
format Online
Article
Text
id pubmed-9611586
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96115862022-10-28 Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders Mareczek, Lena Riehl, Carolin Harms, Meike Reichl, Stephan Pharmaceutics Article The relevance of the polymorphic form, particle size, and processing of mannitol for the mechanical properties of solid oral dosage forms was examined. Thus, particle and powder properties of spray granulated β D-mannitol, β D-mannitol, and δ D-mannitol were assessed in this study with regards to their manufacturability. D-mannitol is a commonly used excipient in pharmaceutical formulations, especially in oral solid dosage forms, and can be crystallized as three polymorphic forms, of which β is the thermodynamically most stable form and δ is a kinetically stabilized polymorph. A systematic analysis of the powders as starting materials and their respective roller compacted granules is presented to elucidate the multidimensional effects of powder and granules characteristics such as polymorphic form, particle size, and preprocessing on the resulting tablets’ mechanical properties. In direct compression and after roller compaction, δ polymorph displayed superior tableting properties over β mannitol, but was outperformed by spray granulated β mannitol. This could be primarily correlated to the higher specific surface area, leading to higher bonding area and more interparticle bonds within the tablet. Hence, it was shown that surface characteristics and preprocessing can prevail over the impact of polymorphism on manufacturability for oral solid dosage forms. MDPI 2022-10-07 /pmc/articles/PMC9611586/ /pubmed/36297563 http://dx.doi.org/10.3390/pharmaceutics14102128 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mareczek, Lena
Riehl, Carolin
Harms, Meike
Reichl, Stephan
Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders
title Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders
title_full Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders
title_fullStr Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders
title_full_unstemmed Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders
title_short Understanding the Multidimensional Effects of Polymorphism, Particle Size and Processing for D-Mannitol Powders
title_sort understanding the multidimensional effects of polymorphism, particle size and processing for d-mannitol powders
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611586/
https://www.ncbi.nlm.nih.gov/pubmed/36297563
http://dx.doi.org/10.3390/pharmaceutics14102128
work_keys_str_mv AT mareczeklena understandingthemultidimensionaleffectsofpolymorphismparticlesizeandprocessingfordmannitolpowders
AT riehlcarolin understandingthemultidimensionaleffectsofpolymorphismparticlesizeandprocessingfordmannitolpowders
AT harmsmeike understandingthemultidimensionaleffectsofpolymorphismparticlesizeandprocessingfordmannitolpowders
AT reichlstephan understandingthemultidimensionaleffectsofpolymorphismparticlesizeandprocessingfordmannitolpowders